|
Mr. Rosengart is currently the President and CEO of HK & Associates, an investment and consulting firm which provides advice to small and medium-sized life sciences companies and life-science investment firms. Previously, he founded several privately held companies, including LigoChem, Inc., a DNA\RNA and macromolecule bioseparations company founded in 1995; SunPharm Corporation, a polyamine based anti-cancer drug development-stage company founded in 1991 and Syncom Pharmaceuticals, Inc., a contract sales force organization founded in 1991. Between 1981 and 1990, Mr. Rosengart spent almost ten years as a banker and investment banker with the Chase Manhattan Bank, NA, focusing on the pharmaceutical and chemical industries. Prior to joining Chase Manhattan Bank, he spent over ten years with several pharmaceutical and chemical multinational companies in various managerial positions. Mr. Rosengart holds a B.S. in Chemical Engineering and an M.B.A. from Rutgers University. | 